- Actemra (tocilizumab)
ACTEMRA is used to treat active moderate to severe rheumatoid arthritis (RA). ACTEMRA is also used to treat active systemic juvenile idiopathic arthritis (sJIA) and active moderate to severe polyarticular juvenile idiopathic arthritis (pJIA) in children over 2 years of age.
- MabThera (RA/GPA/MPA) (rituximab)
MabThera (RA/GPA/MPA) (rituximab)
MABTHERA is used to treat rheumatoid arthritis (RA), Granulomatosis with polyangiitis (Wegener's) (GPA) and Microscopic polyangiitis (MPA).
Consumer Medicine Information (CMI)
1 of 1